Biotech NewsFrom Penny Stock to Powerhouse? AIM ImmunoTech (AIM)’s Comeback Could Be Epic BioTech Health XJuly 4, 2025 AIM ImmunoTech Inc. (NYSE:AIM) traces its roots to 1966, when the company—then known as Hemispherx Biopharma—set out to… 0 Shares 0 0 0 0 0 0 0